Exagen (XGN) Cash from Investing Activities (2018 - 2026)
Exagen (XGN) posted Cash from Investing Activities of -$228000.0 for Q1 2026, down 551.43% quarter-over-quarter from -$35000.0 in Q4 2025, and down 113.08% year-on-year from $1.7 million in Q1 2025.
Exagen (XGN) Cash from Investing Activities (2018 - 2026) Analysis & Trends
Exagen (XGN) has reported Cash from Investing Activities for 9 consecutive years, with -$228000.0 the latest figure, recorded in Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at -$228000.0, down 113.08% year-over-year; the trailing twelve-month figure through Mar 2026 was -$747000.0 (down 39.37% YoY), and the FY2025 annual result was -$626000.0, down 21.55% from the prior year.
- Cash from Investing Activities was -$228000.0 for Q1 2026 at Exagen, down from -$35000.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at -$2000.0 in Q3 2023 and troughed at -$1.9 million in Q2 2022.
- Average Cash from Investing Activities over 5 years is -$381823.5, with a median of -$209000.0 recorded in 2025.
- Year-over-year, Cash from Investing Activities jumped 99.77% in 2023 and plunged 7250.0% in 2024.
- Over 5 years, Cash from Investing Activities stood at -$406000.0 in 2022, then soared by 79.31% to -$84000.0 in 2023, then plunged by 73.81% to -$146000.0 in 2024, then jumped by 76.03% to -$35000.0 in 2025, then slumped by 551.43% to -$228000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$228000.0 in Q1 2026, -$35000.0 in Q4 2025, and -$275000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 95.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | -8.96 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -249.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | -33.54 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -32.14 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -77.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -196.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -366.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -31.35 Mn |
| 10 | Exagen | 112.36 Mn | 90.84 Mn | 10.21 Mn | -228,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -228,000.00 |
| Mar 31, 2026 | -228,000.00 |
| Dec 31, 2025 | -35,000.00 |
| Dec 31, 2025 | -35,000.00 |
| Sep 30, 2025 | -275,000.00 |
| Sep 30, 2025 | -275,000.00 |
| Jun 30, 2025 | -209,000.00 |
| Jun 30, 2025 | -209,000.00 |
| Mar 31, 2025 | -107,000.00 |
| Mar 31, 2025 | -107,000.00 |
| Dec 31, 2024 | -146,000.00 |
| Dec 31, 2024 | -146,000.00 |
| Sep 30, 2024 | -147,000.00 |
| Sep 30, 2024 | -147,000.00 |
| Jun 30, 2024 | -136,000.00 |
| Jun 30, 2024 | -136,000.00 |
| Mar 31, 2024 | -86,000.00 |
| Mar 31, 2024 | -86,000.00 |
| Dec 31, 2023 | -84,000.00 |
| Dec 31, 2023 | -84,000.00 |